SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
SIRICOMM, INC.
(Name of Issuer)
Common Stock, $.001 par value
(Title of Class of Securities)
82967C 10 2
(CUSIP Number of Class of Securities)
Kory S. Dillman
2900 Davis Boulevard, Suite 130
Joplin, Missouri 64804
(417) 626-9961
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
November 21, 2002
(Date of Event which Requires
Filing of this Schedule)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box: [ ]
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 240.13d-7 for other
parties to whom copies are to be sent.
CUSIP No. 82967C 10 2 Page 2 of 5
SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Kory S. Dillman
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]*
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS* OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
1,023,535
NUMBER OF ----------------------------------------------------------------
SHARES 8 SHARED VOTING POWER
OWNED BY ---
EACH ----------------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON WITH 1,023,535
----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
---
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
1,023,535
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.5%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*Mr. Dillman acquired these shares as a result of being a shareholder of
SiriCOMM, Inc. (Missouri), accordingly he may be considered a member of the
group of other shareholders.
CUSIP No. 82967C 10 2 Page 3 of 5
Item 1. Security and Issuer.
This statement on Schedule 13D ("Schedule 13D") is being filed with
respect to the common stock, $0.001 par value (the "Common Stock"), of SiriCOMM,
Inc. (f/k/a Fountain Pharmaceuticals, Inc.), a Delaware corporation (the
"Company"). The Company's principal executive office is located at 2900 Davis
Boulevard, Suite 130, Joplin, Missouri 64804.
Item 2. Identity and Background.
(a) This statement is filed by Kory S. Dillman (the "Reporting Person")
with respect to shares directly owned by him.
Any disclosures herein with respect to persons other than the Reporting
Person is made on information and belief after making inquiry to the appropriate
party.
(b) The business address of Kory S. Dillman is 2900 Davis Boulevard,
Suite 130, Joplin, Missouri 64804.
(c) Mr. Dillman is principally engaged as the Executive Vice President
of SiriCOMM, Inc.
(d) The Reporting Person has not, during the last five years, been
convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors).
(e) The Reporting Person has not, during the last five years, been a
party to a civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a judgment,
decree or final order enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities laws or finding any
violation with respect to such laws.
(f) Mr. Dillman is a citizen of the United States of America.
Item 3. Source and Amount of Funds or Other Consideration.
On November 21, 2002, the Company completed the acquisition of all of
the issued and outstanding shares of SiriCOMM, Inc., a Missouri corporation.
Pursuant to the transaction, the Issuer issued an aggregate of 9,662,562 shares
to the (19) shareholders of SiriCOMM (Missouri). Included in that number of
shares was the 1,023,535 shares issued to Mr. Dillman. The shares of SiriCOMM
(Missouri) that Mr. Dillman exchanged in connection with the above described
transaction were paid for out of personal funds and services rendered by Mr.
Dillman to SiriCOMM (Missouri).
CUSIP No. 82967C 10 2 Page 4 of 5
Item 4. Purpose of Transaction.
The shares of Common Stock deemed to be beneficially owned by Mr.
Dillman were acquired for, and are being held for, investment purposes. The
shares were acquired in connection with the Company's acquisition of SiriCOMM
(Missouri).
The Reporting Person may in the future directly acquire shares of
Common Stock in open market or private transactions, block purchases or
otherwise. The Reporting Person may continue to hold or dispose of all or some
of the securities reported herein from time to time, in each case in open market
or private transactions, block sales or purchases or otherwise, subject to
compliance with applicable law. Other than as set forth herein, the Reporting
Person has no plans or proposals which relate to, or could result in, any of the
matters referred to in paragraphs (b) through (j), inclusive, of Item 4 of the
Schedule 13D. The Reporting Person may, at any time and from time to time,
review or reconsider his or its position and formulate plans or proposals with
respect thereto, but has no present intention of doing so.
Item 5. Interest in Securities of the Issuer.
(a) As of the close of business on November 21, 2002, the Reporting
Person was the beneficial owner, within the meaning of Rule 13d-3 under the
Exchange Act, of 1,023,535 shares of Common Stock. As of November 21, 2002,
these shares represented 10.5% of the sum of the 9,762,253 total shares of
Common Stock outstanding as reported.
(b) The sole or shared power to vote or dispose of, or to direct the
vote or disposition of the Common Stock with respect to each Reporting Person
noted in paragraph (a) of this Item 5 is as set forth on the cover sheets of
this Schedule 13D.
(c) There have been no transactions involving the shares of Common
Stock of the Company engaged in during the 60 day period prior to and including
September 22, 2002 up to the present.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
There are no contracts, arrangements, understandings or relationships
(legal or otherwise) among the Reporting Persons named in Item 2 of this
statement and between such Reporting Persons and any person with respect to any
securities of the Issuer, including but not limited to transfer or voting of any
of the securities, finder's fees, joint ventures, loan or option arrangements,
puts or calls, guarantees of profits, division of profits or loss, or the giving
or withholding of proxies.
Item 7. Material to be Filed as Exhibits.
None
CUSIP No. 82967C 10 2 Page 5 of 5
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct.
Dated: November 21, 2002 /s/ Kory S. Dillman
----------------------------
Kory S. Dillman